Group Luncheon Meeting with Management to be held in New York on November 20 hosted by Oppenheimer.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HRMY:
- Harmony Biosciences price target raised to $39 from $36 at Mizuho
- Harmony Biosciences Holdings: Strong Q3 Performance and Growth Potential Justify Buy Rating
- Harmony Biosciences Reports Strong Q3 2025 Results
- Harmony Biosciences Q3 Earnings Call Highlights Robust Growth
- Promising Outlook for Harmony Biosciences: Buy Rating Affirmed Due to Strong Product Momentum and Pipeline Progress